Boothbay Fund Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,000
Closed -$735K 1608
2024
Q3
$735K Buy
+50,000
New +$697K 0.02% 846
2023
Q2
Sell
-276,000
Closed -$2.59M 1936
2023
Q1
$2.59M Sell
276,000
-300
-0.1% -$3.54K 0.05% 544
2022
Q4
$3.38M Buy
276,300
+205,400
+290% +$2.56M 0.08% 371
2022
Q3
$880K Buy
70,900
+29,500
+71% +$516K 0.02% 942
2022
Q2
$813K Buy
41,400
+4,700
+13% +$111K 0.02% 920
2022
Q1
$958K Buy
+36,700
New +$977K 0.02% 934
2021
Q4
Sell
-20,200
Closed -$644K 1948
2021
Q3
$644K Buy
+20,200
New +$678K 0.02% 967

Other funds holding ELAN

Boothbay Fund Management's ELAN Position: Q1 2025 in Review

Boothbay Fund Management sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 2,055,567 shares — an estimated $24.9M sold.

Boothbay Fund Management first reported a position in ELAN in Q3 2019 and held it in 19 quarters. The position peaked at $28.3M in Q3 2023. 364 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • Boothbay Fund Management reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 2,055,567 Elanco Animal Health shares in Q1 2025, an estimated $24.9M.
  • Boothbay Fund Management first reported a position in Elanco Animal Health in Q3 2019 and held it in 19 quarters.
  • Boothbay Fund Management's Elanco Animal Health position peaked at $28.3M in Q3 2023.
  • 364 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.